MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors.

Cancer Research
Alexa B TurkeJeffrey A Engelman

Abstract

The phosphoinositide 3-kinase (PI3K)/AKT and RAF/MEK/ERK signaling pathways are activated in a wide range of human cancers. In many cases, concomitant inhibition of both pathways is necessary to block proliferation and induce cell death and tumor shrinkage. Several feedback systems have been described in which inhibition of one intracellular pathway leads to activation of a parallel signaling pathway, thereby decreasing the effectiveness of single-agent targeted therapies. In this study, we describe a feedback mechanism in which MEK inhibition leads to activation of PI3K/AKT signaling in EGFR and HER2-driven cancers. We found that MEK inhibitor-induced activation of PI3K/AKT resulted from hyperactivation of ERBB3 as a result of the loss of an inhibitory threonine phosphorylation in the conserved juxtamembrane domains of EGFR and HER2. Mutation of this amino acid led to increased ERBB receptor activation and upregulation of the ERBB3/PI3K/AKT signaling pathway, which was no longer responsive to MEK inhibition. Taken together, these results elucidate an important, dominant feedback network regulating central oncogenic pathways in human cancer.

References

Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K TakishimaM R Rosner
Dec 14, 1999·The Journal of Biological Chemistry·B RoshanL G Cantley
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·A John DiamontiKermit L Carraway
Sep 24, 2004·Biochemistry·Stefan LehrDirk Muller-Wieland
Feb 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey A EngelmanLewis C Cantley
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen
Aug 15, 2006·The Journal of Clinical Investigation·Jeffrey A EngelmanPasi A Jänne
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tammie C YehEli Wallace
Jul 7, 2007·Cancer Cell·David A Guertin, David M Sabatini
Aug 2, 2007·British Journal of Cancer·A C Hsieh, M M Moasser
Mar 8, 2008·Current Opinion in Genetics & Development·Jeffrey A Engelman, Jeffrey Settleman
Aug 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·S Michael RothenbergJeffrey Settleman
Feb 17, 2009·Cancer Letters·Clara Montagut, Jeff Settleman
Jun 30, 2009·Molecular Cell·Monica Red BrewerGraham Carpenter
Jul 1, 2009·Cell·Stevan R Hubbard
Jul 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Klaus P HoeflichMark R Lackner
Jul 25, 2009·Nature Reviews. Cancer·Jeffrey A Engelman
Sep 2, 2009·Molecular and Cellular Biology·Christian C DibbleBrendan D Manning
Oct 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Anthony C FaberJeffrey A Engelman
Feb 5, 2010·Cancer Cell·Alexa B TurkePasi A Jänne
Sep 28, 2010·Seminars in Cell & Developmental Biology·Kermit L Carraway
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Anindita ChakrabartyCarlos L Arteaga
Oct 12, 2011·The Journal of Clinical Investigation·Hiromichi EbiJeffrey A Engelman

❮ Previous
Next ❯

Citations

Feb 28, 2013·Cancer Chemotherapy and Pharmacology·Carolyn D Britten
Sep 26, 2013·Science Signaling·Matthew J Niederst, Jeffrey A Engelman
Aug 9, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick J RobertsNorman E Sharpless
Dec 12, 2012·PloS One·Roberta Lelis DutraAdriana Madeira Álvares da Silva
Sep 23, 2014·Trends in Biochemical Sciences·Chong Sun, René Bernards
Jan 30, 2013·Cancer Discovery·Georgia KonstantinidouPier Paolo Scaglioni
May 29, 2013·Nature Reviews. Clinical Oncology·Geoffrey T GibneyKeiran S M Smalley
Sep 26, 2015·International Journal of Molecular Sciences·Sally TemrazAli Shamseddine
Oct 28, 2014·Cancer Investigation·Hongsheng WangZhengdong Cai
Jul 3, 2015·International Journal of Oncology·Elina Jokinen, Jussi P Koivunen
Aug 30, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ernest NadalNithya Ramnath
Aug 26, 2014·Journal of Cellular Biochemistry·Manish TandonJitesh Pratap
Feb 10, 2016·Trends in Cancer·Meagan B RyanAdrienne D Cox
Feb 24, 2015·Oncogene·E Pazarentzos, T G Bivona
Jul 31, 2013·Journal of Neurochemistry·Deepak K KaushikAnirban Basu
Dec 3, 2014·Journal of the American Academy of Dermatology·Martina SanlorenzoSusana Ortiz-Urda
Sep 25, 2015·Nature Reviews. Cancer·Christopher J CauntSimon J Cook
Aug 12, 2014·Biochemical Society Transactions·Edmund H WilkesPedro R Cutillas
Jun 25, 2016·Current Colorectal Cancer Reports·Donna M GrahamRichard H Wilson
Mar 22, 2014·Cancer Cell·Andrew G StephenFrank McCormick
Nov 7, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P García-AlfonsoUNKNOWN Spanish Society of Medical Oncology
Feb 11, 2015·Current Gastroenterology Reports·Stacey Shiovitz, William M Grady
Sep 10, 2014·Cell Reports·Simona LambaAlberto Bardelli
Oct 23, 2016·Cellular and Molecular Life Sciences : CMLS·David LakeJürgen Müller
Jul 9, 2016·Small GTPases·Hidenori Kitai, Hiromichi Ebi
Jul 14, 2016·Expert Opinion on Therapeutic Patents·Katarzyna A Ludwik, Deborah A Lannigan
Sep 30, 2016·Scientific Reports·Anup S PathaniaFayaz Malik
Oct 25, 2016·Current Biology : CB·Keqiang XieKirill A Martemyanov

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.